Inotuzumab Ozogamicin (IO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) as Frontline Therapy for Older Patients (pts) and as Salvage Therapy for Adult with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
Titel:
Inotuzumab Ozogamicin (IO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) as Frontline Therapy for Older Patients (pts) and as Salvage Therapy for Adult with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
Auteur:
Jabbour, Elias O’Brien, Susan Thomas, Deborah Sasaki, Koji Garcia-Manero, Guillermo Ravandi, Farhad Borthakur, Gautam York, Sergermne Garris, Rebecca Cortes, Jorge Kantarjian, Hagop